Avid Radiopharmaceuticals
Avid develops molecular imaging agents to aid medical management of chronic human diseases. They are located in Philadelphia, PA. Their mission is to develop new molecular imaging agents capable of changing the medical management of significant, chronic human diseases by identifying the first stages of pathological change, potentially assisting in earlier diagnosis, and better management and development of new therapies.
Industries
biotechnology
diabetes
pharmaceutical
Nr. of Employees
medium (51-250)
Avid Radiopharmaceuticals
Philadelphia, Pennsylvania, United States, North America
Products
Amyvid
A PET imaging agent approved by the FDA for detecting beta-amyloid plaques in the brain.
Tauvid
An FDA-approved PET imaging agent for detecting tau pathology in patients being evaluated for Alzheimer's disease.
Amyvid
A PET imaging agent approved by the FDA for detecting beta-amyloid plaques in the brain.
Tauvid
An FDA-approved PET imaging agent for detecting tau pathology in patients being evaluated for Alzheimer's disease.